OINDPnews

RDD Europe 2025 preview

The upcoming RDD Europe 2025 conference in Estoril, Portugal will mark the 20th anniversary of the … [Read More...] about RDD Europe 2025 preview

DDL 2024 in review

DDL 2024 drew the largest crowd ever in the 35-year history of the Drug Delivery to the Lung (DDL), … [Read More...] about DDL 2024 in review

DDL 2024 to celebrate 35 years as a leading OINDP conference

The annual Drug Delivery to the Lungs (DDL) conference will mark its 35th anniversary during this … [Read More...] about DDL 2024 to celebrate 35 years as a leading OINDP conference

Akita gets Flu Lab grant for study of Profi nasal spray

Akita Biosciences announced that a grant from Flu Lab will fund a pilot study of the company's Profi prophylactic nasal spray in healthcare workers. Akita launched Profi, an OTC gel-forming drug-free nasal spray, in 2023 and currently sells the product online. The 8-week study will enroll workers in … [Read More...] about Akita gets Flu Lab grant for study of Profi nasal spray

Iconovo announces it will downsize and focus on commercialization of existing DPI platforms

Swedish DPI developer Iconovo has announced that it will lay off about 10 employees as it switches its focus to commercialization of its existing dry powder inhalation platforms, including the ICOres reservoir-based DPI, the ICOpre generic version of Ellipta, and the ICOone single use device in both … [Read More...] about Iconovo announces it will downsize and focus on commercialization of existing DPI platforms

Rein Therapeutics gets 2 new US patents covering its LTI-03 DPI

Rein Therapeutics says that the US Patent and Trademark Office (USPTO) has recently granted US Patents No. 12,280,088 and No. 12,280,089, which cover the dry powder peptide formulation of the company's lead candidate, LTI-03. Both of the new patents are titled "Dry Powder Formulation of Caveolin-1 … [Read More...] about Rein Therapeutics gets 2 new US patents covering its LTI-03 DPI

Kindeva names Melanie Cerullo as Chief Quality Officer

CDMO Kindeva has announced the appointment of Melanie Cerullo as Chief Quality Officer. Cerullo was most recently Chief Quality and Regulatory Officer at Recipharm's ReciBioPharm business unit and previously served in quality roles at Wave Life Sciences, Ameridose, and Amgen. Since the beginning … [Read More...] about Kindeva names Melanie Cerullo as Chief Quality Officer

Nanopharm announces clinical study to validate SmartTrack platform for demonstration of BE for inhaled drug products

AptarGroup announced that its subsidiary Nanopharm is initiating a clinical study to validate the SmartTrack in-vitro-in-silico modeling platform as an alternative to clinical endpoint studies for determining bioequivalence of inhaled drug products. The study will also collect PK data for validation … [Read More...] about Nanopharm announces clinical study to validate SmartTrack platform for demonstration of BE for inhaled drug products

More news . . .